Last reviewed: June 18, 2026
Last updated: June 18, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Wegovy contains semaglutide, a medication that mimics glucagon-like peptide-1, a natural hormone that controls hunger and blood sugar. Clinical trials show patients taking semaglutide lose up to 22% of their body weight over 68 weeks. PlexusDx delivers compounded semaglutide injections through licensed 503A pharmacies to all 50 states at lower monthly costs than brand-name alternatives.
How Semaglutide Works in Your Body
Semaglutide activates GLP-1 receptors in your brain's appetite control centers, significantly reducing hunger signals and food cravings. The medication also slows stomach emptying, keeping you feeling full longer after meals. These dual mechanisms work together to lower your total daily calorie intake without requiring extreme diet restriction.
Your pancreas naturally produces GLP-1 in response to eating, but semaglutide provides a sustained, therapeutic dose throughout the week. This consistent hormone signal helps regulate blood sugar levels and can improve metabolic markers beyond weight loss alone. Most patients begin noticing appetite reduction within the first week of starting treatment.
Wegovy vs. Compounded Semaglutide: Key Differences
Wegovy is Novo Nordisk's branded version of semaglutide, sold by prescription at significantly higher retail prices. PlexusDx compounded semaglutide contains the identical active ingredient, manufactured by licensed 503A compounding pharmacies that follow FDA quality standards. The compounded version is dispensed in single-use pens or vials and costs substantially less—starting at just $149 monthly—with no insurance requirement.
Both forms use the same weekly injection schedule and dose escalation protocol, beginning at 0.25 mg and increasing over 4 to 5 weeks. The main advantages of PlexusDx compounded semaglutide are affordability, accessibility across all states, and HSA/FSA eligibility. Your dose may need to go up. Your price won't.
Semaglutide Dosing and Your Weight Loss Timeline
Treatment begins with a 0.25 mg injection once weekly, increasing by 0.25 mg every week or two until reaching your optimal therapeutic dose, typically between 1.0 and 2.4 mg per week. This gradual escalation allows your body to adjust and minimizes nausea and digestive side effects. Most patients experience meaningful appetite suppression and weight loss within 4 to 8 weeks of starting.
PlexusDx provides personalized dose guidance based on your health history, but clinical response varies among individuals. The Precision Peptide Genetic Test identifies genetic variants in GLP1R, GIPR, and FTO genes that influence your medication response, helping predict whether you'll be a strong or moderate responder. Knowing your genetic profile helps PlexusDx healthcare providers optimize your starting dose and escalation timing for faster results.
Common Side Effects and How to Manage Them
Nausea is the most frequently reported side effect during the first two weeks of semaglutide treatment, affecting 40% to 50% of users. Mild nausea typically resolves within a few days as your body adapts. Slower dose escalation, eating smaller meals, and avoiding fatty or greasy foods significantly reduce gastrointestinal symptoms.
Other possible side effects include constipation, fatigue, and reduced appetite for previously enjoyed foods—all temporary and generally mild. Serious side effects are rare but include pancreatitis symptoms (severe abdominal pain), allergic reactions, and thyroid concerns; report these immediately to your healthcare provider. PlexusDx patients have access to clinical support teams who monitor side effects and adjust treatment plans as needed.
Cost and Access: Why PlexusDx Compounded Semaglutide Makes Sense
Brand-name Wegovy costs $1,300 to $1,500 monthly without insurance coverage, placing it out of reach for many patients. PlexusDx compounded semaglutide starts at just $149 per month with flat pricing across all dose levels—meaning your dose can increase without your monthly cost increasing. This pricing transparency removes barriers and makes medically supervised weight loss accessible nationwide.
PlexusDx serves all 50 states without requiring health insurance, accepting HSA and FSA funds for additional savings. Medications ship directly from licensed 503A compounding pharmacies, ensuring quality and consistency. First-month patients can add the Precision Peptide Genetic Test for $99, uncovering personalized genetic insights into your weight loss potential across 14 metabolic pathways and 49 peptide targets.
Clinical Evidence: What Studies Show About Semaglutide
The STEP clinical trial program demonstrated that patients receiving weekly semaglutide injections achieved 15% to 22% body weight reduction over 68 weeks, compared to 2% to 3% in placebo groups. These results were independent of diet alone and represent the most robust weight loss evidence available for any injectable medication. Participants maintained weight loss for at least one year after reaching their therapeutic dose.
Beyond weight, semaglutide improved cardiovascular risk markers including blood pressure, lipid profiles, and inflammatory markers in trial participants. These metabolic improvements often occur before significant weight loss, suggesting the medication benefits your health through multiple mechanisms. PlexusDx treatment protocols align with these evidence-based clinical standards.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is compounded semaglutide as safe as brand-name Wegovy?
Yes. PlexusDx sources semaglutide from licensed 503A compounding pharmacies that follow strict FDA quality and sterility standards. Compounded medications contain identical active ingredients and concentrations as brand versions, with the same injection frequency and safety profile.
How long do I need to take semaglutide for weight loss?
Most patients benefit from 6 to 12 months of treatment to reach their goal weight. Some continue long-term to maintain results, as weight often returns after stopping. PlexusDx providers work with you to establish realistic timelines based on your starting weight, health status, and personal goals.
Can I use my HSA or FSA to pay for PlexusDx semaglutide?
Yes. PlexusDx compounded semaglutide is HSA and FSA eligible, allowing you to use pre-tax healthcare funds. This additional savings can reduce your effective monthly cost below the stated pricing.
What happens to my weight if I stop taking semaglutide?
Weight regain occurs in many patients after stopping semaglutide, though the rate varies individually. Some weight typically returns within 6 to 12 months, though often patients remain below their starting weight. PlexusDx supports patients who choose longer-term treatment to maintain results and prevent weight cycling.
How does the Precision Peptide Genetic Test personalize my semaglutide treatment?
The $99 test identifies genetic variants in GLP1R, GIPR, FTO, and MC4R genes that influence your metabolic rate, appetite regulation, and medication response. Results guide your PlexusDx provider in predicting whether you'll respond as a strong or moderate responder, optimizing your starting dose and dose escalation schedule for your unique genetic profile.
Do I need a doctor's prescription to start PlexusDx semaglutide?
Yes. PlexusDx requires a clinical evaluation and prescription from a healthcare provider. The PlexusDx team can connect you with licensed physicians who specialize in weight management and can authorize treatment within 24 to 48 hours.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is It Better to Lose Weight Naturally or with Ozempic?
Navigating Your Journey: When Does Ozempic Start Working?